Agilent Technologies (A) vs Natera (NTRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Natera (NTRA) has outperformed Agilent Technologies (A) over the past year, gaining 134.7% versus a gain of 22.0%. Over five years, NTRA leads with a +257.1% price change compared with +10.3% for A. Natera is the larger company by market cap ($57.02 billion vs $47.68 billion), about 1.2 times the size.
Agilent Technologies pays a dividend yielding 0.60%, while Natera does not currently pay one. Agilent Technologies converts more of its revenue into profit, with a net margin of 18.8% versus -9.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | A | NTRA |
|---|---|---|
| Share price | $169.09 | $395.56 |
| Market cap | $47.68B | $57.02B |
| 1-day change | -0.14% | -1.27% |
| YTD return | +24.27% | +72.67% |
| 1-year return | +22.03% | +134.71% |
| 5-year return | +10.32% | +257.10% |
| P/E ratio (TTM) | 33.35 | — |
| Forward P/E | 25.02 | — |
| EPS (TTM) | $5.07 | $-1.35 |
| Dividend yield | 0.60% | 0.00% |
| Annual dividend | $1.01 | $0.00 |
| Revenue (latest FY) | $6.95B | $2.31B |
| Revenue growth (YoY) | +6.73% | +35.90% |
| Net income (latest FY) | $1.30B | $-208.16M |
| Gross margin | 52.43% | — |
| Operating margin | 21.29% | -13.44% |
| Net margin | 18.75% | -9.03% |
| 52-week high | $177.05 | $437.41 |
| 52-week low | $108.35 | $167.99 |
| Distance from 52-week high | -4.50% | -9.57% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +4.38% | -4.58% |
| Average volume | 2.26M | 1.44M |
| Shares outstanding | 281.97M | 144.14M |
| Employees | 18,200 | 6,135 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NTRA has outperformed A by 112.7 percentage points over the past year.
- Agilent Technologies is more profitable, keeping 18.8 cents of every revenue dollar as net income versus -9.0 cents for Natera.
- Natera grew revenue faster in its latest fiscal year (+35.90% vs +6.73%).
- The two companies sit in different sectors: Agilent Technologies in Industrials and Natera in Health Care.
About Agilent Technologies
A stock →Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Industrials · Biotechnology: Laboratory Analytical Instruments · 18,200 employees
About Natera
NTRA stock →Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test.
Health Care · Medical Specialities · 6,135 employees
A vs NTRA FAQ
Which is bigger, Agilent Technologies or Natera?
Natera (NTRA) is larger, with a market capitalization of $57.02B compared with $47.68B for Agilent Technologies (A).
Which stock has performed better over the past year, A or NTRA?
NTRA returned +134.71% over the past 12 months, compared with +22.03% for A (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Agilent Technologies or Natera?
Agilent Technologies pays a dividend yielding 0.60%, while Natera does not currently pay a regular dividend.
Are Agilent Technologies and Natera in the same industry?
No. Agilent Technologies is in the Industrials sector, while Natera is in Health Care.